ArticleACS chemical neuroscience2022

O-GlcNAcase Inhibitor ASN90 is a Multimodal Drug Candidate for Tau and α-Synuclein Proteinopathies.

Bruno Permanne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.